Heat, light, or contamination exposure can cause the medication to degrade more quickly, reducing its effectiveness
Start with the first five
Although anaphylaxis to tirzepatide is rare, it is a recognised risk with any injectable medication
What are these patients most common complaints
As the new obesity pharmacotherapies will lead up to 1525% mean WL, intensive lifestyle interventions may provide small additional WL benefit to these treatments [11, 106]
Indications and Usage Saxenda (liraglutide [rDNA origin] injection) is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or greater (obese) or 27 kg/m 2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)